MediFind Announced as Finalist for Reuter’s Pharma Awards USA: Most Valuable Service or Digital Therapy

MediFind announced as finalist for Reuters Award

The Reuters Events’ Pharma Awards USA focus on what really matters: value for patients and customers. Recognizing innovative and meaningful approaches: this is the work worth applauding. The awards focus on initiatives that deliver outcomes, restore pharma’s reputation and celebrate real achievements.

Specifically, the Most Valuable Service or Digital Therapy category focuses on initiatives that go beyond the pill, providing a holistic service or solution that provides significant benefit to patients.

The formal awards ceremony is scheduled for December 7-9, 2020. Read more about the award and the other finalists here.

Relevant Articles

  • MediFind selected as Finalist for Best in Artificial Intelligence in the Shorty Social Good Awards

    The Shorty Social Good Awards honor the social good initiatives brands, agencies & nonprofits are taking to make our world a better place.

  • MediFind Announced as Vesalius Innovation and Sierra Ventures Finalist

    Advanced platform helps people facing the most challenging health conditions quickly find medical experts and treatment options when every second counts

    MediFind announced as finalist for Vesalius Innovation Award and Sierra Ventures Startup 50
  • Primary Care Physician | The Ultimate Guide to Choosing a Primary Care Doctor

    The ultimate guide on how to find, evaluate, and choose the best primary care physician. 10-step process and checklist included.